Tandem Diabetes Care, Inc. (TNDM) Social Stream
TANDEM DIABETES CARE INC (TNDM) Price Targets From Analysts
Use the tables below to see what analysts covering TANDEM DIABETES CARE INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 10 | $154 | $90 | $127.3 | $26.44 | 381.47% |
| 2021-12-06 | 9 | $154 | $90 | $128.111 | $26.44 | 384.53% |
| 2021-12-19 | 7 | $170 | $90 | $133.5 | $26.44 | 404.92% |
| 2022-02-23 | 8 | $170 | $90 | $136.444 | $26.44 | 416.05% |
| 2022-02-24 | 7 | $170 | $90 | $135.375 | $26.44 | 412.01% |
| 2022-03-01 | 7 | $170 | $90 | $134.777 | $26.44 | 409.75% |
| 2022-05-06 | 9 | $160 | $90 | $122.888 | $26.44 | 364.78% |
| 2022-05-17 | 9 | $160 | $100 | $127.333 | $26.44 | 381.59% |
| 2022-08-05 | 7 | $150 | $72 | $97.6 | $26.44 | 269.14% |
| 2022-08-13 | 7 | $150 | $49 | $94.3 | $26.44 | 256.66% |
| 2022-09-19 | 7 | $150 | $49 | $92.8 | $26.44 | 250.98% |
| 2022-10-05 | 7 | $150 | $49 | $90.5 | $26.44 | 242.28% |
| 2022-10-12 | 8 | $150 | $49 | $89.09 | $26.44 | 236.95% |
| 2022-10-18 | 9 | $150 | $49 | $87.916 | $26.44 | 232.51% |
| 2022-11-03 | 9 | $150 | $45 | $71.923 | $26.44 | 172.02% |
| 2022-11-04 | 9 | $80 | $45 | $61.923 | $26.44 | 134.2% |
| 2022-11-08 | 9 | $80 | $45 | $61.077 | $26.44 | 131% |
| 2022-11-15 | 9 | $80 | $43.001 | $60.615 | $26.44 | 129.25% |
| 2023-02-08 | 9 | $80 | $43.001 | $59.077 | $26.44 | 123.44% |
| 2023-04-19 | 10 | $74 | $40 | $55 | $26.44 | 108.02% |
| 2023-05-05 | 10 | $74 | $38 | $54.166 | $26.44 | 104.86% |
| 2023-06-06 | 11 | $74 | $33 | $52.333 | $26.44 | 97.93% |
| 2023-06-15 | 12 | $71 | $33 | $50.333 | $26.44 | 90.37% |
| 2023-08-04 | 12 | $71 | $33 | $49.25 | $26.44 | 86.27% |
| 2023-08-07 | 12 | $62 | $33 | $43.333 | $26.44 | 63.89% |
| 2023-09-27 | 12 | $62 | $30 | $42.25 | $26.44 | 59.8% |
| 2023-10-02 | 12 | $62 | $30 | $42.083 | $26.44 | 59.16% |
| 2023-10-16 | 13 | $62 | $21 | $39.846 | $26.44 | 50.7% |
| 2023-10-18 | 13 | $62 | $18 | $38.692 | $26.44 | 46.34% |
| 2023-11-03 | 13 | $62 | $17 | $28.416 | $26.44 | 7.47% |
| 2023-11-20 | 13 | $40 | $17 | $26.666 | $26.44 | 0.85% |
| 2023-12-15 | 13 | $40 | $17 | $27.5 | $26.44 | 4.01% |
| 2023-12-22 | 13 | $40 | $17 | $28.333 | $26.44 | 7.16% |
The Trend in the Analyst Price Target
TNDM's average price target has moved down $26.05 over the prior 40 weeks.
TNDM reports an average of 62.15% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-05 | 10 | 74 | 38 | 54.166 | 35.06 | 54.5% |
| 2023-05-05 | 11 | 74 | 33 | 53.166 | 35.06 | 51.64% |
| 2023-08-21 | 12 | 62 | 30 | 42.250 | 27.79 | 52.03% |
| 2023-11-03 | 13 | 40 | 17 | 26.500 | 15.75 | 68.25% |
| 2023-11-03 | 13 | 62 | 17 | 28.416 | 15.75 | 80.42% |
TNDM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.15 | 6 | 0 | 6 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
TNDM's average broker recommendation rating worsened by 0.26 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TNDM as an investment opportunity.
- TNDM has a higher upside potential (average analyst target price relative to current price) than 4444.17% of all US stocks.
- TANDEM DIABETES CARE INC's variance in analysts' estimates is lower than -4119.71% of all US stocks.
- In the context of stocks in the mid market cap category, TANDEM DIABETES CARE INC's average analyst price target is higher than 4148.41% of them.
- TANDEM DIABETES CARE INC's number of analysts covering the stock is higher than 3723.78% of stocks in the mid market cap category.
Stocks similar to TANDEM DIABETES CARE INC in the Medical Equipment industry regarding analyst recommendations and price targets are NVRO, ATEC, and ATRC.
View All Top Stocks by Price Target
Is TNDM a Buy, Hold or Sell? See the POWR Ratings now!